Assessment For Markers Of Poor Prognosis In A Real-World Evidence Study Of Treatment Patterns In Patients With Hr+/Her2-Locally Advanced Or Metastatic Breast Cancer In Korea And Taiwan.
JOURNAL OF CLINICAL ONCOLOGY（2020）
Abstract
e13083Background: To assess how patient characteristics impact treatment patterns and real-world effectiveness among patients with hormone receptor (HR+)/human epidermal growth receptor 2-negative ...
MoreTranslated text
Key words
Clinical Characteristics,Metastatic Breast Cancer,Prognostic Markers
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined